COVID-19 and leprosy-hurdles and possible solutions
Main Authors: | Pugazhenthan Thangaraju, Maheshkumar Arulmani, Sajitha Venkatesan, Meenalotchini Prakash Gurunthalingam, Eswaran Thangaraju |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Asian Pacific Journal of Tropical Medicine |
Online Access: | http://www.apjtm.org/article.asp?issn=1995-7645;year=2020;volume=13;issue=10;spage=472;epage=473;aulast=Thangaraju |
Similar Items
-
COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-06-01) -
COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01) -
COVID 19'da N95 maskesinin yeniden kullanımı pandemik stratejiler ve ihtiyat
by: Pugazhenthan Thangaraju, et al.
Published: (2020-09-01) -
Leprosy in Children: Needs for Active Intervention
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01) -
De novo histoid leprosy - Further points of focus
by: Sajitha Venkatesan, et al.